Download the full event guide to examine the technical developments in the identification and validation of novel epigenetic modulators, stabilizers, chromatin remodels and post-translational modification-inducing modalities for previously undrugged targets. Along with the development of first-in-class heterobifunctionals, explore the development of bispecific antibodies for improved targeted degradation and how ADCs are improving the payload of induced proximity drugs.
What you can expect...
- 60+ Attendees
- 20+ World-Class Speakers
- 9+ Hours Networking
- 2 Deep Dive Pre-Conference Workshops
- 17+ Data Driven Presentations
![The 4th induced proximity-based drug discovery summit The 4th induced proximity-based drug discovery summit - includes biotech and pharma companies such as Astellas, Astrazeneca, Magnet Biomedicine, and novartis](https://induced-proximity-summit.com/wp-content/uploads/sites/475/2024/07/IPBDD-Brochure-Image.png)
Having trouble downloading the brochure?
Let us know here and we’ll email it to you instead.
Companies Already Attending
![Untitled design4th induced proximity-based drug discovery summit companies attending biotech and pharma The 4th induced proximity-based drug discovery summit - includes biotech and pharma companies such as Astellas, Astrazeneca, Magnet Biomedicine, and novartis](https://induced-proximity-summit.com/wp-content/uploads/sites/475/2024/07/Untitled-design.gif)